Leading-Edge Research Investigation
Leading-Edge InvestigationThe Neurosciences Critical Care Center participates in numerous clinical trials benefiting current and future critically ill patients.

Among current trials are the following NIH-sponsored studies:
  • ATACH (Antihypertensive Treatment in Acute Cerebral Hemorrhage)
  • ALIAS (Albumin in Acute Ischemic Stroke trial)
  • IMS (Interventional Management of Stroke) III –  Studying the management of acute ischemic stroke with interventional or angiographically based treatment
  • ARUBA (A Randomized  Trial of Unruptured Brain AVMs) – to study the natural history of AVMs. Our participation in trials gives patients the opportunity to receive new therapeutic treatments that may not be available elsewhere.